During the past decade, Providence Access Care conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Providence Access Care" are "Restenosis" (3 trials), "Stenosis" (2 trials) and "Arteriovenous Fistula" (1 trials). Many other conditions were trialed in "Providence Access Care" in a lesser frequency.

Most popular intervention types in "Providence Access Care" are "Device" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Covera Vascular Covered Stent" (1 trials), "Covera Vascular Covered Stent following PTA" (1 trials), "Covera(TM) Vascular Covered Stent" (1 trials), "Fluency Plus Endovascular Stent Graft" (1 trials) and "Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Access Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Providence Access Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Providence Access Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Access Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".